[ad_1]
The American pharmaceutical company Pfizer and the German biotechnology company Bioentech claim that their Covid-19 vaccine is capable of providing more than 90 percent protection to humans.
The two companies described the day as a “memorable day for science and humanity,” with preliminary results from Ticker’s “third stage” test.
According to the BBC, the Pfizer and Bioentech vaccines have been tested in 43,000 people in six countries. So far no illnesses or physical complications have been reported. No safety concerns were raised.
Authorities at Pfizer and BioTech are trying to get their tickers approved urgently later this month.
Due to the coronavirus epidemic, the people of the world are deprived of a normal life throughout the year. His daily work takes place under the siege of various prohibitions. As a result, the world economy has contracted alarmingly.
But the chances of getting rid of this deadly infectious disease with restrictions are slim, it has been proven in so many days. In most countries, the second wave of coronavirus infection is already underway, and there are signs that it will be more severe than the first.
More than five million people around the world have already been infected with the disease. More than 12 lakh people have died. Vaccination may be the most effective way to get rid of this deadly disease.
Many countries and companies around the world are working around the clock to discover the vaccine for Covid-19. About a dozen of these final stage tests (heads up to three) are in progress. But this is the first time that a ticker test has yielded such effective results.
Pfizer, a US pharmaceutical company, says it believes it will be able to deliver 50 million doses this year and 1.3 billion doses by the end of 2021.
According to the BBC, the UK expects them to receive 10 million doses of vaccine this year. Three more dose crore tickers have been ordered.
However, the task of preserving this tick is quite difficult. This is because the vaccine must be stored at temperatures below minus 60 degrees Celsius.
Professor Ur Sahin, a founding member of the German company Bioentech, called the results of the vaccine tests a “milestone”. Many scientific research institutes around the world have described the vaccine as a “significant advance in science.”
Peter Herbie, a professor at the University of Oxford, said: “The news made me smile.
” It’s the joy of liberation … even though this vaccine still has a long way to go to make a real difference. But it seems like a turning point to me. “
[ad_2]
